Substance · stimulant

Amphetamines & methamphetamine

The amphetamines class on the federal panel covers amphetamine, methamphetamine, MDMA and MDA. Immunoassay screens have a high false-positive rate; confirmation by mass spectrometry is essential, and MRO review accounts for prescriptions (e.g., legitimate ADHD medications).

Last updated:

What is Amphetamines & methamphetamine?

A group of phenethylamine stimulants. Federal panels test for amphetamine, methamphetamine, MDMA, and MDA. The d-/l-isomer ratio of methamphetamine helps confirmation labs distinguish illicit methamphetamine from over-the-counter Vicks-type l-methamphetamine.

Panels that include Amphetamines & methamphetamine

What drug tests detect

Drug tests for Amphetamines & methamphetamine typically target the following analytes / metabolites:

  • Amphetamine (from methamphetamine)
  • MDA (from MDMA)

Confirmation testing uses GC-MS or LC-MS/MS.

Detection windows

Approximate detection windows for Amphetamines & methamphetamine
Specimen Window Pattern Caveat
Urine 1–3 days occasional Urinary pH affects excretion of methamphetamine and amphetamine.
3–5 days chronic Heavy use can extend the window modestly.
Saliva 1–48 hours typical Detects parent compound; window is short.
Blood 1–48 hours typical Plasma half-life varies by isomer.
Hair 7–90 days typical ~7–10 day incorporation delay.

Ranges are approximate and vary by individual physiology, hydration, dose, frequency of use, and lab cutoff. They are not predictive of whether someone will "pass" a test.

Cross-reactivity and MRO interpretation

The following can affect initial immunoassay screening and are normally resolved by mass-spectrometry confirmation and MRO review. None of these are a reason to draw conclusions from a single screening result.

  • Pseudoephedrine and other OTC decongestants
  • Bupropion
  • Selegiline (metabolized to methamphetamine)
  • Ranitidine (historical)

Sources & references

drugtest.co content is sourced from primary regulatory and clinical references. We do not cite gray-market or "how to pass" sources.

  1. Mandatory Guidelines for Federal Workplace Drug Testing Programs (Urine) — SAMHSA
  2. 49 CFR Part 40 — Procedures for Transportation Workplace Drug and Alcohol Testing Programs — U.S. Department of Transportation